Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015

Be the first to review this product

Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, 'Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015' provides an...
You can choose to pay by purchase order during checkout

Availability: In stock

$4,000.00

* Required Fields

You can choose to pay by purchase order during checkout
GlobalData.

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, 'Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015' provides an overview of Auto-Immune Diseases currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Auto-Immune Diseases pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Auto-Immune Diseases under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Auto-Immune Diseases and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Auto-Immune Diseases under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Additional Information

Additional Information

Publisher name GlobalData.
Format PDF
Page count 295
Publication date 5 Jan 2016
Table of contents 1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 18
2 Introduction 19
2.1 Auto-Immune Diseases Overview 19
3 Products under Development 20
3.1 Auto-Immune Diseases - Pipeline Products by Stage of Development 20
3.2 Auto-Immune Diseases - Pipeline Products by Territory 21
3.3 Auto-Immune Diseases - Pipeline Products by Regulatory Path 22
3.4 Auto-Immune Diseases - Pipeline Products by Estimated Approval Date 23
4 Auto-Immune Diseases - Pipeline Products under Development by Companies 24
4.1 Auto-Immune Diseases Companies - Pipeline Products by Stage of Development 24
4.2 Auto-Immune Diseases - Pipeline Products by Stage of Development 28
5 Auto-Immune Diseases Companies and Product Overview 35
5.1 Adaptive Biotechnologies Corporation Company Overview 35
5.1.1 Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
5.2 Agena Bioscience, Inc Company Overview 36
5.2.1 Agena Bioscience, Inc Pipeline Products & Ongoing Clinical Trials Overview 36
5.3 Albert-Ludwigs-Universitat Freiburg Company Overview 37
5.3.1 Albert-Ludwigs-Universitat Freiburg Pipeline Products & Ongoing Clinical Trials Overview 37
5.4 Alere Inc. Company Overview 40
5.4.1 Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.5 Amarantus Bioscience Holdings, Inc. Company Overview 43
5.5.1 Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.6 Amdix B.V. Company Overview 46
5.6.1 Amdix B.V. Pipeline Products & Ongoing Clinical Trials Overview 46
5.7 Analyticon Biotechnologies AG Company Overview 47
5.7.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 47
5.8 apDia n.v. Company Overview 48
5.8.1 apDia n.v. Pipeline Products & Ongoing Clinical Trials Overview 48
5.9 Autoimmune Technologies, LLC Company Overview 49
5.9.1 Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 49
5.10 Beckman Coulter, Inc. Company Overview 55
5.10.1 Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.11 BG Medicine, Inc. Company Overview 57
5.11.1 BG Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.12 Biocortech Company Overview 59
5.12.1 Biocortech Pipeline Products & Ongoing Clinical Trials Overview 59
5.13 Biogen, Inc. Company Overview 60
5.13.1 Biogen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.14 Biomedal S.L. Company Overview 62
5.14.1 Biomedal S.L. Pipeline Products & Ongoing Clinical Trials Overview 62
5.15 Biomerica, Inc. Company Overview 66
5.15.1 Biomerica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.16 Bionure Farma, S.L. Company Overview 70
5.16.1 Bionure Farma, S.L. Pipeline Products & Ongoing Clinical Trials Overview 70
5.17 Bio-Rad Laboratories, Inc. Company Overview 71
5.17.1 Bio-Rad Laboratories, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.18 BioRap Technologies Ltd. Company Overview 73
5.18.1 BioRap Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 73
5.19 Boston University Company Overview 74
5.19.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 74
5.20 CareDx, Inc. Company Overview 75
5.20.1 CareDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.21 CD Diagnostics, Inc. Company Overview 77
5.21.1 CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.22 Chronix Biomedical, Inc. Company Overview 78
5.22.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.23 Co-Diagnostics HBDC, Inc. Company Overview 81
5.23.1 Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.24 Crescendo Bioscience, Inc. Company Overview 82
5.24.1 Crescendo Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
5.25 Digna Biotech, S.L. Company Overview 86
5.25.1 Digna Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 86
5.26 Durin Technologies, Inc. Company Overview 90
5.26.1 Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.27 Enterome Bioscience SA Company Overview 91
5.27.1 Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview 91
5.28 Ezose Sciences Inc. Company Overview 93
5.28.1 Ezose Sciences Inc. Pipeline Products & Ongoing Clinical Trials Overview 93
5.29 Flamentera AG Company Overview 94
5.29.1 Flamentera AG Pipeline Products & Ongoing Clinical Trials Overview 94
5.30 Genalyte, Inc. Company Overview 95
5.30.1 Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.31 Genentech, Inc. Company Overview 96
5.31.1 Genentech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 96
5.32 GeNeuro SA Company Overview 99
5.32.1 GeNeuro SA Pipeline Products & Ongoing Clinical Trials Overview 99
5.33 Glycominds Ltd. Company Overview 101
5.33.1 Glycominds Ltd. Pipeline Products & Ongoing Clinical Trials Overview 101
5.34 Grifols, S.A. Company Overview 102
5.34.1 Grifols, S.A. Pipeline Products & Ongoing Clinical Trials Overview 102
5.35 Hannover Medical School Company Overview 104
5.35.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 104
5.36 Helmholtz Centre for Infection Research Company Overview 105
5.36.1 Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview 105
5.37 HOB Biotech Group Co., Ltd. Company Overview 106
5.37.1 HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 106
5.38 Hospital for Special Surgery Company Overview 107
5.38.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 107
5.39 Hycor Biomedical Inc. Company Overview 108
5.39.1 Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 108
5.40 Ignyta, Inc. Company Overview 110
5.40.1 Ignyta, Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.41 ImmusanT, Inc. Company Overview 114
5.41.1 ImmusanT, Inc. Pipeline Products & Ongoing Clinical Trials Overview 114
5.42 Innobiochips Company Overview 115
5.42.1 Innobiochips Pipeline Products & Ongoing Clinical Trials Overview 115
5.43 INOVA Diagnostics, Inc. Company Overview 116
5.43.1 INOVA Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 116
5.44 Institut National de la Sante et de la Recherche Medicale Company Overview 126
5.44.1 Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview 126
5.45 Is Diagnostics Company Overview 127
5.45.1 Is Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 127
5.46 LineaGen, Inc. Company Overview 128
5.46.1 LineaGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 128
5.47 Lophius Biosciences GmbH Company Overview 129
5.47.1 Lophius Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 129
5.48 Louisville Bioscience, Inc. Company Overview 130
5.48.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 130
5.49 Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Company Overview 134
5.49.1 Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Pipeline Products & Ongoing Clinical Trials Overview 134
5.50 Medica Corporation Company Overview 135
5.50.1 Medica Corporation Pipeline Products & Ongoing Clinical Trials Overview 135
5.51 Metabolomic Technologies Inc. Company Overview 138
5.51.1 Metabolomic Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 138
5.52 Metanomics Health GmbH Company Overview 142
5.52.1 Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 142
5.53 MSDx, Inc. Company Overview 143
5.53.1 MSDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 143
5.54 Myriad Genetics, Inc. Company Overview 147
5.54.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 147
5.55 Nanosphere, Inc. Company Overview 149
5.55.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 149
5.56 Neuro Vigor, LLC Company Overview 151
5.56.1 Neuro Vigor, LLC Pipeline Products & Ongoing Clinical Trials Overview 151
5.57 Northwestern University Company Overview 152
5.57.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 152
5.58 NoToPharm s.r.l. Company Overview 154
5.58.1 NoToPharm s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 154
5.59 NOWDiagnostics Company Overview 162
5.59.1 NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 162
5.60 OmniBiome Therapeutics Inc. Company Overview 163
5.60.1 OmniBiome Therapeutics Inc. Pipeline Products & Ongoing Clinical Trials Overview 163
5.61 One Way Liver Genomics, S.L. Company Overview 164
5.61.1 One Way Liver Genomics, S.L. Pipeline Products & Ongoing Clinical Trials Overview 164
5.62 OPKO Health, Inc. Company Overview 166
5.62.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 166
5.63 Oxford Gene Technology Limited Company Overview 168
5.63.1 Oxford Gene Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 168
5.64 Oxford Immunotec Limited Company Overview 169
5.64.1 Oxford Immunotec Limited Pipeline Products & Ongoing Clinical Trials Overview 169
5.65 Pediatric Bioscience, LLC Company Overview 170
5.65.1 Pediatric Bioscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 170
5.66 Progentec Diagnostics, Inc. Company Overview 171
5.66.1 Progentec Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 171
5.67 Protagen AG Company Overview 172
5.67.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 172
5.68 ProteinLogic Ltd Company Overview 182
5.68.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview 182
5.69 Quanterix Corporation Company Overview 183
5.69.1 Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview 183
5.70 Regulus Therapeutics Inc. Company Overview 184
5.70.1 Regulus Therapeutics Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.71 Rice University Company Overview 186
5.71.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 186
5.72 Roche Diagnostics International Ltd. Company Overview 187
5.72.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 187
5.73 Shuwen Biotech Co. Ltd. Company Overview 193
5.73.1 Shuwen Biotech Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 193
5.74 Singulex, Inc. Company Overview 194
5.74.1 Singulex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 194
5.75 SomaLogic, Inc. Company Overview 195
5.75.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 195
5.76 Southern Illinois University Carbondale Company Overview 196
5.76.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 196
5.77 SQI Diagnostics Inc. Company Overview 198
5.77.1 SQI Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 198
5.78 The Johns Hopkins University Company Overview 207
5.78.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 207
5.79 The Walter and Eliza Hall Institute of Medical Research Company Overview 210
5.79.1 The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 210
5.80 TheraDiag SA Company Overview 211
5.80.1 TheraDiag SA Pipeline Products & Ongoing Clinical Trials Overview 211
5.81 Thermo Fisher Scientific Inc. Company Overview 213
5.81.1 Thermo Fisher Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview 213
5.82 Toscana Biomarkers Srl Company Overview 237
5.82.1 Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview 237
5.83 Univalue Valorizacion, S.L. Company Overview 243
5.83.1 Univalue Valorizacion, S.L. Pipeline Products & Ongoing Clinical Trials Overview 243
5.84 University of California, San Francisco Company Overview 244
5.84.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 244
5.85 University of Chicago Company Overview 247
5.85.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 247
5.86 University of Colorado Company Overview 248
5.86.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 248
5.87 University of Florida Company Overview 249
5.87.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 249
5.88 University of Manchester Company Overview 250
5.88.1 University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 250
5.89 University of Oxford Company Overview 252
5.89.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 252
5.90 University of Pecs Company Overview 256
5.90.1 University of Pecs Pipeline Products & Ongoing Clinical Trials Overview 256
5.91 University Rovira i Virgili Company Overview 257
5.91.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 257
5.92 US Biomarkers, Inc. Company Overview 258
5.92.1 US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 258
5.93 Washington University in St. Louis Company Overview 259
5.93.1 Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview 259
5.94 XAir Diagnostics B.V. Company Overview 260
5.94.1 XAir Diagnostics B.V. Pipeline Products & Ongoing Clinical Trials Overview 260
5.95 XEPTAGEN SpA Company Overview 261
5.95.1 XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview 261
5.96 Yale University Company Overview 262
5.96.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 262
6 Auto-Immune Diseases- Recent Developments 263
7 Appendix 292
7.1 Methodology 292
7.2 About GlobalData 294
7.3 Contact Us 295
7.4 Disclaimer 295

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.